|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 247.6 CHF | +0.73% |
|
+2.06% | +1.27% |
By Michael Susin
The U.K. Competition and Markets Authority said it launched a merger inquiry regarding whether a deal for Roche Holding to buy certain companies linked to LumiraDx's point-of-care technology could hurt competition in the country.
The CMA said Friday that it has until July 19 to reach a phase one decision.
Both companies weren't immediately available for comments.
Write to Michael Susin at michael.susin@wsj.com
(END) Dow Jones Newswires
05-24-24 0226ET
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 247.6 CHF | +0.73% | +2.06% | 225B | ||
| 0.0143 USD | +29.06% | +26.55% | 5.13M | ||
| 1st Jan change | Capi. | |
|---|---|---|
| +1.27% | 225B | |
| +41.96% | 630B | |
| -7.15% | 350B | |
| +18.77% | 328B | |
| +8.79% | 298B | |
| +18.02% | 246B | |
| +11.95% | 218B | |
| +3.68% | 160B | |
| -4.38% | 156B | |
| -3.71% | 116B |
ROCHE HOLDING AG 
